Many seriously ill people die waiting for the FDA to approve drugs that regulators in other advanced countries have already ...

U.S. policies that fix the IRA, strengthen patents, and incentivize antimicrobial research could help hasten new medicines ...

Ijeoma Uchegbu discusses nanomedicine's role in improving medication adherence and developing non-addictive pain relief ...

Prosper Africa’s Tech for Trade Alliance (AT4T) said that it will be launching a pilot programme in Africa to test a digital ...

Tempus AI's growth and partnerships make it an attractive investment. See why TEM stock is a solid Buy due to its ...

While A.I. promises breakthroughs, industry leaders warn that transparency and patient safety must remain front and center.

Can we protect the 5,000-year legacy of medicinal plants and their multi-billion-dollar market value from climate change?

Pharmacists face growing challenges as Congress considers vital healthcare legislation to preserve access to community pharmacies.

And while its potential is exciting, the current AI models have a long way to go before they disrupt medicine, according to pharmaceutical executive Taggart McGurrin. That doesn’t mean AI won’t ...

The Quadruple Aim—a framework originally rooted in improving patient experience, enhancing population health, and achieving ...

On Tuesday night, millions of Americans watched as former president Donald J. Trump gathered up enough electoral votes needed ...

Compounded medicine plays an essential role in personalized healthcare. Unlike mass-produced pharmaceutical drugs, compounded ...